One explanation for these findings is that lung cancer in never or minimal smokers is generally associated with a low TMB [10], another predictive biomarker of response to immune checkpoint inhibitors, independent of PDL1 expression [41] . This evidence concerns the gene CD274 and lung carcinoma.